These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15334543)

  • 1. Structural integrity and expression of the L3MBTL gene in normal and malignant hematopoietic cells.
    MacGrogan D; Kalakonda N; Alvarez S; Scandura JM; Boccuni P; Johansson B; Nimer SD
    Genes Chromosomes Cancer; 2004 Nov; 41(3):203-13. PubMed ID: 15334543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the imprinted polycomb gene L3MBTL, a candidate 20q tumour suppressor gene, in patients with myeloid malignancies.
    Bench AJ; Li J; Huntly BJ; Delabesse E; Fourouclas N; Hunt AR; Deloukas P; Green AR
    Br J Haematol; 2004 Dec; 127(5):509-18. PubMed ID: 15566354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.
    Lawrence HJ; Sauvageau G; Ahmadi N; Lopez AR; LeBeau MM; Link M; Humphries K; Largman C
    Exp Hematol; 1995 Oct; 23(11):1160-6. PubMed ID: 7556525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. UK Cancer Cytogenetics Group (UKCCG).
    Bench AJ; Nacheva EP; Hood TL; Holden JL; French L; Swanton S; Champion KM; Li J; Whittaker P; Stavrides G; Hunt AR; Huntly BJ; Campbell LJ; Bentley DR; Deloukas P; Green AR
    Oncogene; 2000 Aug; 19(34):3902-13. PubMed ID: 10952764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
    Boultwood J; Pellagatti A; Watkins F; Campbell LJ; Esoof N; Cross NC; Eagleton H; Littlewood TJ; Fidler C; Wainscoat JS
    Br J Haematol; 2004 Aug; 126(4):508-11. PubMed ID: 15287943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L3mbtl, the mouse orthologue of the imprinted L3MBTL, displays a complex pattern of alternative splicing and escapes genomic imprinting.
    Li J; Bench AJ; Piltz S; Vassiliou G; Baxter EJ; Ferguson-Smith AC; Green AR
    Genomics; 2005 Oct; 86(4):489-94. PubMed ID: 16081246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A human homolog of Drosophila lethal(3)malignant brain tumor (l(3)mbt) protein associates with condensed mitotic chromosomes.
    Koga H; Matsui S; Hirota T; Takebayashi S; Okumura K; Saya H
    Oncogene; 1999 Jul; 18(26):3799-809. PubMed ID: 10445843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
    Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
    Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folylpoly-gamma-glutamate synthetase gene mRNA splice variants and protein expression in primary human leukemia cells, cell lines, and normal human tissues.
    Leclerc GJ; Barredo JC
    Clin Cancer Res; 2001 Apr; 7(4):942-51. PubMed ID: 11309345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
    Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
    Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
    Lepelley P; Preudhomme C; Vanrumbeke M; Quesnel B; Cosson A; Fenaux P
    Leukemia; 1994 Aug; 8(8):1342-9. PubMed ID: 8057671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A heterozygous frameshift mutation in the Fanconi anemia C gene in familial T-ALL and secondary malignancy.
    Rischewski JR; Clausen H; Leber V; Niemeyer C; Ritter J; Schindler D; Schneppenheim R
    Klin Padiatr; 2000; 212(4):174-6. PubMed ID: 10994546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
    Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
    Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple splicing variants of Naf1/ABIN-1 transcripts and their alterations in hematopoietic tumors.
    Shiote Y; Ouchida M; Jitsumori Y; Ogama Y; Matsuo Y; Ishimaru F; Tanimoto M; Shimizu K
    Int J Mol Med; 2006 Nov; 18(5):917-23. PubMed ID: 17016622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome.
    Hofmann WK; Takeuchi S; Takeuchi N; Thiel E; Hoelzer D; Koeffler HP
    Leuk Res; 2006 Nov; 30(11):1347-53. PubMed ID: 16682076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCL expression at critical points in human hematopoietic lineage commitment.
    Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
    Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma.
    Hu N; Flaig MJ; Su H; Shou JZ; Roth MJ; Li WJ; Wang C; Goldstein AM; Li G; Emmert-Buck MR; Taylor PR
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6013-22. PubMed ID: 15447985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imprinting of the human L3MBTL gene, a polycomb family member located in a region of chromosome 20 deleted in human myeloid malignancies.
    Li J; Bench AJ; Vassiliou GS; Fourouclas N; Ferguson-Smith AC; Green AR
    Proc Natl Acad Sci U S A; 2004 May; 101(19):7341-6. PubMed ID: 15123827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    Harada Y; Harada H
    J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.